Variations in HDL-carried miR-223 and miR-135a concentrations after consumption of dietary trans fat are associated with changes in blood lipid and inflammatory markers in healthy men - an exploratory study

References

• Alwan A, Armstrong T, Bettcher D, Branca F, Chisholm D, Ezzati M, Garfield R, MacLean D, Mathers C, Mendis S, et al. Global status report on noncommunicable diseases 2010. Chapter 1: Burden: mortality, morbidity and risk factors. World Health Organization (WHO) 2011:9-31
   Google Scholar
• Alwan A, Armstrong T, Bettcher D, Boerma T, Branca F, Ho JCY, Mathers C, Martinez R, Poznyak V, Roglic G, et al. Global atlas on cardiovascular disease prevention and control. Section A: Cardiovascular diseases due to atherosclerosis. In: Mendis S, Puska P, Norrving B, eds.: World Health Organization, in collaboration with the World Heart Federation and the World Stroke Organization; 2011:18-32.
   Google Scholar
• Wardhana, Surachmanto ES, Datau EA. The role of omega-3 fatty acids contained in olive oil on chronic inflammation. Acta Med Indones 2011; 43:138-43; PMID:21785178
   PubMedGoogle Scholar
• Brouwer IA, Wanders AJ, Katan MB. Trans fatty acids and cardiovascular health: research completed? Eur J Clin Nutr 2013; 67:541-7; PMID:23531781; http://dx.doi.org/10.1038/ejcn.2013.43
   PubMed Web of Science ®Google Scholar
• Stender S, Dyerberg J. Influence of trans fatty acids on health. Ann Nutr Metab 2004; 48:61-6; PMID:14679314; http://dx.doi.org/10.1159/000075591
   PubMed Web of Science ®Google Scholar
• Da Silva MS, Julien P, Perusse L, Vohl MC, Rudkowska I. Natural rumen-derived trans fatty acids are associated with metabolic markers of cardiac health. Lipids 2015; 50:873-82; PMID:26210489; http://dx.doi.org/10.1007/s11745-015-4055-3
   PubMed Web of Science ®Google Scholar
• Willett WC. Trans fatty acids and cardiovascular disease-epidemiological data. Atheroscler Suppl 2006; 7:5-8; PMID:16713753; http://dx.doi.org/10.1016/j.atherosclerosissup.2006.04.002
   PubMed Web of Science ®Google Scholar
• Ganguly R, Pierce GN. Trans fat involvement in cardiovascular disease. Mol Nutr Food Res 2012; 56:1090-6; PMID:22760981; http://dx.doi.org/10.1002/mnfr.201100700
   PubMed Web of Science ®Google Scholar
• Nestel P. Trans fatty acids: are its cardiovascular risks fully appreciated? Clin Ther 2014; 36:315-21; PMID:24636816; http://dx.doi.org/10.1016/j.clinthera.2014.01.020
   PubMed Web of Science ®Google Scholar
• Katan MB, Zock PL, Mensink RP. Trans fatty acids and their effects on lipoproteins in humans. Annu Rev Nutr 1995; 15:473-93; PMID:8527230; http://dx.doi.org/10.1146/annurev.nu.15.070195.002353
   PubMed Web of Science ®Google Scholar
• Motard-Belanger A, Charest A, Grenier G, Paquin P, Chouinard Y, Lemieux S, Couture P, Lamarche B. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 2008; 87:593-9; PMID:18326596
   PubMed Web of Science ®Google Scholar
• Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004; 79:969-73; PMID:15159225
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, Willett WC, Rimm EB. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004; 79:606-12; PMID:15051604
   PubMed Web of Science ®Google Scholar
• Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005; 135:562-6; PMID:15735094
   PubMed Web of Science ®Google Scholar
• Bendsen NT, Stender S, Szecsi PB, Pedersen SB, Basu S, Hellgren LI, Newman JW, Larsen TM, Haugaard SB, Astrup A. Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women. J Lipid Res 2011; 52:1821-8; PMID:21795740; http://dx.doi.org/10.1194/jlr.M014738
   PubMed Web of Science ®Google Scholar
• Gayet-Boyer C, Tenenhaus-Aziza F, Prunet C, Marmonier C, Malpuech-Brugere C, Lamarche B, Chardigny JM. Is there a linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomised clinical trials. Br J Nutr 2014; 112:1914-22; PMID:25345440; http://dx.doi.org/10.1017/S0007114514002578
   PubMed Web of Science ®Google Scholar
• Gebauer SK, Chardigny JM, Jakobsen MU, Lamarche B, Lock AL, Proctor SD, Baer DJ. Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies. Adv Nutr 2011; 2:332-54; PMID:22332075; http://dx.doi.org/10.3945/an.111.000521
   PubMed Web of Science ®Google Scholar
• Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996; 124(Suppl):S11-20; PMID:8831911; http://dx.doi.org/10.1016/0021-9150(96)05852-2
   PubMed Web of Science ®Google Scholar
• Annema W, von Eckardstein A. High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis. Circ J 2013; 77:2432-48; PMID:24067275; http://dx.doi.org/10.1253/circj.CJ-13-1025
   PubMed Web of Science ®Google Scholar
• Luscher TF, von Eckardstein A, Simic B. Therapeutic targets to raise HDL in patients at risk or with coronary artery disease. Curr Vasc Pharmacol 2012; 10:720-4; PMID:23259565; http://dx.doi.org/10.2174/157016112803520972
   PubMed Web of Science ®Google Scholar
• Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res 2009; 50(Suppl):S189-94; PMID:19064999
   PubMed Web of Science ®Google Scholar
• Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990; 1044:275-83; PMID:2344447; http://dx.doi.org/10.1016/0005-2760(90)90314-N
   PubMed Web of Science ®Google Scholar
• Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res 2004; 95:764-72; PMID:15486323; http://dx.doi.org/10.1161/01.RES.0000146094.59640.13
   PubMed Web of Science ®Google Scholar
• Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res 2006; 98:1352-64; PMID:16763172; http://dx.doi.org/10.1161/01.RES.0000225982.01988.93
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SP, Remaley AT, Sviridov D, Chin-Dusting J. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 2008; 28:2071-7; PMID:18617650; http://dx.doi.org/10.1161/ATVBAHA.108.168690
   PubMed Web of Science ®Google Scholar
• Fryirs MA, Barter PJ, Appavoo M, Tuch BE, Tabet F, Heather AK, Rye KA. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler Thromb Vasc Biol 2010; 30:1642-8; PMID:20466975; http://dx.doi.org/10.1161/ATVBAHA.110.207373
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011; 13:423-33; PMID:21423178; http://dx.doi.org/10.1038/ncb2210
   PubMed Web of Science ®Google Scholar
• Tabet F, Vickers KC, Cuesta Torres LF, Wiese CB, Shoucri BM, Lambert G, Catherinet C, Prado-Lourenco L, Levin MG, Thacker S, et al. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat Commun 2014; 5:3292; PMID:24576947; http://dx.doi.org/10.1038/ncomms4292
   PubMed Web of Science ®Google Scholar
• Kim GH. MicroRNA regulation of cardiac conduction and arrhythmias. Transl Res 2013; 161:381-92; PMID:23274306; http://dx.doi.org/10.1016/j.trsl.2012.12.004
   PubMed Web of Science ®Google Scholar
• Bratkovic T, Glavan G, Strukelj B, Zivin M, Rogelj B. Exploiting microRNAs for cell engineering and therapy. Biotechnol Adv 2012; 30:753-65; PMID:22286072; http://dx.doi.org/10.1016/j.biotechadv.2012.01.006
   PubMed Web of Science ®Google Scholar
• (WHO) WHO. A global brief on hypertension: Silent killer, global public health crisis. Section II: Hypertension; the basic facts. In: WHO, ed., 2013:17.
   Google Scholar
• Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, Couture P, Dufour R, Fodor G, Francis GA, et al. 2009 Canadian cardiovascular society/canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 2009; 25:567-79; PMID:19812802; http://dx.doi.org/10.1016/S0828-282X(09)70715-9
   PubMed Web of Science ®Google Scholar
• Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation 2003; 107:370-1; PMID:12551854; http://dx.doi.org/10.1161/01.CIR.0000053731.05365.5A
   PubMed Web of Science ®Google Scholar
• Weissglas-Volkov D, Pajukanta P. Genetic causes of high and low serum HDL-cholesterol. J Lipid Res 2010; 51:2032-57; PMID:20421590; http://dx.doi.org/10.1194/jlr.R004739
   PubMed Web of Science ®Google Scholar
• Gagné C, Gaudet D. Les Dyslipoprotéinémies: L'approche Clinique. Chapitre 3 : Les lipides et les lipoproténes.: Lipimed communications, 2007. 25-39.
   Google Scholar
• Sorensen CJ, Pedersen OB, Petersen MS, Sorensen E, Kotze S, Thorner LW, Hjalgrim H, Rigas AS, Moller B, Rostgaard K, et al. Combined oral contraception and obesity are strong predictors of low-grade inflammation in healthy individuals: results from the Danish Blood Donor Study (DBDS). PLoS One 2014; 9:e88196; PMID:24516611; http://dx.doi.org/10.1371/journal.pone.0088196
   PubMed Web of Science ®Google Scholar
• Condorelli G, Latronico MV, Cavarretta E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol 2014; 63:2177-87; PMID:24583309; http://dx.doi.org/10.1016/j.jacc.2014.01.050
   PubMed Web of Science ®Google Scholar
• Novak J, Bienertova-Vasku J, Kara T, Novak M. MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatment. Mediators Inflamm 2014; 2014:275867; PMID:24876669; http://dx.doi.org/10.1155/2014/275867
   PubMed Web of Science ®Google Scholar
• Ortega FJ, Cardona-Alvarado MI, Mercader JM, Moreno-Navarrete JM, Moreno M, Sabater M, Fuentes-Batllevell N, Ramirez-Chavez E, Ricart W, Molina-Torres J, et al. Circulating profiling reveals the effect of a polyunsaturated fatty acid-enriched diet on common microRNAs. J Nutr Biochem 2015; 26:1095-101; PMID:26092372; http://dx.doi.org/10.1016/j.jnutbio.2015.05.001
   PubMed Web of Science ®Google Scholar
• Marques-Rocha JL, Milagro FI, Mansego ML, Zulet MA, Bressan J, Martinez JA. Expression of inflammation-related miRNAs in white blood cells from subjects with metabolic syndrome after 8 wk of following a Mediterranean diet-based weight loss program. Nutrition Jan 2016; 32(1):48-55; PMID:26421388
   PubMed Web of Science ®Google Scholar
• Tabet F, Cuesta Torres LF, Ong KL, Shrestha S, Choteau SA, Barter PJ, Clifton P, Rye KA. High-density lipoprotein-associated miR-223 is altered after diet-induced weight loss in overweight and obese males. PLoS One 2016; 11:e0151061; PMID:26962854; http://dx.doi.org/10.1371/journal.pone.0151061
   PubMed Web of Science ®Google Scholar
• Taibi F, Metzinger-Le Meuth V, Massy ZA, Metzinger L. miR-223: An inflammatory oncomiR enters the cardiovascular field. Biochim Biophys Acta 2014; 1842:1001-9; PMID:24657505; http://dx.doi.org/10.1016/j.bbadis.2014.03.005
   PubMed Web of Science ®Google Scholar
• Haneklaus M, Gerlic M, O'Neill LA, Masters SL. miR-223: infection, inflammation and cancer. J Intern Med 2013; 274:215-26; PMID:23772809; http://dx.doi.org/10.1111/joim.12099
   PubMed Web of Science ®Google Scholar
• Chuang TY, Wu HL, Chen CC, Gamboa GM, Layman LC, Diamond MP, Azziz R, Chen YH. MicroRNA-223 expression is upregulated in insulin resistant human adipose tissue. J Diabetes Res 2015; 2015:943659; PMID:26273679; http://dx.doi.org/10.1155/2015/943659
   PubMed Web of Science ®Google Scholar
• Zhuang G, Meng C, Guo X, Cheruku PS, Shi L, Xu H, Li H, Wang G, Evans AR, Safe S, et al. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 2012; 125:2892-903; PMID:22580331; http://dx.doi.org/10.1161/CIRCULATIONAHA.111.087817
   PubMed Web of Science ®Google Scholar
• Vickers KC, Landstreet SR, Levin MG, Shoucri BM, Toth CL, Taylor RC, Palmisano BT, Tabet F, Cui HL, Rye KA, et al. MicroRNA-223 coordinates cholesterol homeostasis. Proc Natl Acad Sci U S A 2014; 111:14518-23; PMID:25246565; http://dx.doi.org/10.1073/pnas.1215767111
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001; 358:2026-33; PMID:11755609; http://dx.doi.org/10.1016/S0140-6736(01)07098-2
   PubMed Web of Science ®Google Scholar
• Palmer CS, DeHart M, Zhang X, Feilotter H, Lloyd AR, Zekry A. Hepatic microRNA 135a* regulates hepatic triglyceride storage and is repressed during HCV infection. Poster 844. The Liver Meeting 2010 (AASLD). John B. Boston, Massachusetts, USA: Hynes Convention Center, 2010.
   Google Scholar
• Martinez D. Obesity associated inflammatory mediators in chronic HCV infection and chronic liver disease. Medical Sciences, Australia: Faculty of Medicine: University of New South Wales, 2014:171.
   Google Scholar
• Master SR, Rader DJ. Beyond LDL cholesterol in assessing cardiovascular risk: apo B or LDL-P? Clin Chem 2013; 59:723-5; PMID:23487171; http://dx.doi.org/10.1373/clinchem.2013.203208
   PubMed Web of Science ®Google Scholar
• Skeggs JW, Morton RE. LDL and HDL enriched in triglyceride promote abnormal cholesterol transport. J Lipid Res 2002; 43:1264-74; PMID:12177170
   PubMed Web of Science ®Google Scholar
• Krogager TP, Nielsen LV, Kahveci D, Dyrlund TF, Scavenius C, Sanggaard KW, Enghild JJ. Hepatocytes respond differently to major dietary trans fatty acid isomers, elaidic acid and trans-vaccenic acid. Proteome Sci 2015; 13:31; PMID:26628894; http://dx.doi.org/10.1186/s12953-015-0084-3
   PubMed Web of Science ®Google Scholar
• Gordis L. Epidemiology. Chapter 7: Assessing preventive and therapeutic measures: Randomized trials. 2013. 138-154.
   Google Scholar
• Bender R, Lange S. Adjusting for multiple testing–when and how? J Clin Epidemiol 2001; 54:343-9; PMID:11297884; http://dx.doi.org/10.1016/S0895-4356(00)00314-0
   PubMed Web of Science ®Google Scholar
• Rudkowska I, Paradis AM, Thifault E, Julien P, Barbier O, Couture P, Lemieux S, Vohl MC. Differences in metabolomic and transcriptomic profiles between responders and non-responders to an n-3 polyunsaturated fatty acids (PUFAs) supplementation. Genes Nutr 2013; 8:411-23; PMID:23250786; http://dx.doi.org/10.1007/s12263-012-0328-0
   PubMed Web of Science ®Google Scholar
• Lohmann TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign, Ill: Human Kinetics Books; 1988.
   Google Scholar
• Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34:1345-53; PMID:13252080; http://dx.doi.org/10.1172/JCI103182
   PubMed Web of Science ®Google Scholar
• Kirstein P, Carlson K. Determination of the cholesterol content of high density lipoprotein subfractions HDL2 and HDL3, without contamination of Lp(a), in human plasma. Clin Chim Acta 1981; 113:123-34; PMID:6454513; http://dx.doi.org/10.1016/0009-8981(81)90146-7
   PubMed Web of Science ®Google Scholar
• Moorjani S, Dupont A, Labrie F, Lupien PJ, Brun D, Gagne C, Giguere M, Belanger A. Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism 1987; 36:244-50; PMID:3102895; http://dx.doi.org/10.1016/0026-0495(87)90183-1
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502; PMID:4337382
   PubMed Web of Science ®Google Scholar
• van Deventer HE, Miller WG, Myers GL, Sakurabayashi I, Bachmann LM, Caudill SP, Dziekonski A, Edwards S, Kimberly MM, Korzun WJ, et al. Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population. Clin Chem 2011; 57:490-501; PMID:21228254; http://dx.doi.org/10.1373/clinchem.2010.154773
   PubMed Web of Science ®Google Scholar
• Laurell CB. Electroimmuno assay. Scand J Clin Lab Invest Suppl 1972; 124:21-37; PMID:4114358; http://dx.doi.org/10.3109/00365517209102748
   PubMedGoogle Scholar
• Hafiane A, Genest J. High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk. BBA Clin 2015; 3:175-88; PMID:26674734; http://dx.doi.org/10.1016/j.bbacli.2015.01.005
   PubMed Web of Science ®Google Scholar
• Fainaru M, Glangeaud MC, Eisenberg S. Radioimmunoassay of human high density lipoprotein apo-protein A-1. Biochim Biophys Acta 1975; 386:432-43; PMID:166665; http://dx.doi.org/10.1016/0005-2795(75)90286-X
   PubMed Web of Science ®Google Scholar
• Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, de Kleijn DP, Choo A, Lim SK. Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics 2012; 2012:971907; PMID:22852084; http://dx.doi.org/10.1155/2012/971907
   PubMedGoogle Scholar
• Sourvinou IS, Markou A, Lianidou ES. Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability. J Mol Diagn 2013; 15:827-34; PMID:23988620; http://dx.doi.org/10.1016/j.jmoldx.2013.07.005
   PubMed Web of Science ®Google Scholar
• Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179; PMID:16314309; http://dx.doi.org/10.1093/nar/gni178
   PubMed Web of Science ®Google Scholar
• Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010; 50:298-301; PMID:20146939; http://dx.doi.org/10.1016/j.ymeth.2010.01.032
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3:1101-8; PMID:18546601; http://dx.doi.org/10.1038/nprot.2008.73
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• SAS Institute Inc, ed. Base SAS® 9.2 procedures guide: statistical procedures. Cary, NC: SAS Institute Inc; 2010.
   Google Scholar
• El Harchaoui K, Arsenault BJ, Franssen R, Despres JP, Hovingh GK, Stroes ES, Otvos JD, Wareham NJ, Kastelein JJ, Khaw KT, et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med 2009; 150:84-93; PMID:19153411; http://dx.doi.org/10.7326/0003-4819-150-2-200901200-00006
   PubMed Web of Science ®Google Scholar